Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agentADJEI, Alex A.Clinical cancer research. 2004, Vol 10, Num 12, pp 4276s-4280s, issn 1078-0432, 2Conference Paper

Acute generalized exanthematous pustulosislike drug eruption induced by pemetrexedHATTORI, Tomoyasu; TAMURA, Atsushi; ISHIKAWA, Osamu et al.EJD. European journal of dermatology. 2011, Vol 21, Num 6, pp 998-999, issn 1167-1122, 2 p.Article

2009: l'année de la maintenance en première ligne ? = 2009: the year of first-line maintenance?PEROL, M.Revue de pneumologie clinique (Paris). 2009, Vol 65, issn 0761-8417, S75-S79, SUP2Conference Paper

Physical and chemical stability of pemetrexed in infusion solutionsYANPING ZHANG; TRISSEL, Lawrence A.The Annals of pharmacotherapy. 2006, Vol 40, Num 6, pp 1082-1085, issn 1060-0280, 4 p.Article

Physical and chemical stability of pemetrexed solutions in plastic syringesYANPING ZHANG; TRISSEL, Lawrence A.The Annals of pharmacotherapy. 2005, Vol 39, Num 12, pp 2026-2028, issn 1060-0280, 3 p.Article

Pemetrexed Safety and Pharmacokinetics in Patients with Third-Space FluidDICKGREBER, Nicolas J; BENN SORENSEN, Jens; PAZ-ARES, Luis G et al.Clinical cancer research (Print). 2010, Vol 16, Num 10, pp 2872-2880, issn 1078-0432, 9 p.Article

Pemetrexed-induced Hyperpigmentation of the SkinSCHALLIER, D; DECOSTER, L; DE GREVE, J et al.Anticancer research. 2011, Vol 31, Num 5, pp 1753-1755, issn 0250-7005, 3 p.Article

Primary pericardial mesotheliomaSANTOS, Cristina; MONTESINOS, Jesus; CASTAFIER, Eva et al.Lung cancer. 2008, Vol 60, Num 2, pp 291-293, issn 0169-5002, 3 p.Article

An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markersYUJIA WEN; GAMAZON, Eric R; BLEIBEL, Wasim K et al.Human molecular genetics (Print). 2012, Vol 21, Num 7, pp 1470-1480, issn 0964-6906, 11 p.Article

Asteatotic eczema ('eczema craquelé') with histopathological interface dermatitis: a new cutaneous reaction following pemetrexedFROUIN, E; SEBILLE, G; FREUDENBERGER, S et al.British journal of dermatology (1951). 2012, Vol 166, Num 6, pp 1359-1360, issn 0007-0963, 2 p.Article

pH-Dependent Transport of Pemetrexed by Breast Cancer Resistance ProteinLI LI; YIN SHAM, Yuk; BIKADI, Zsolt et al.Drug metabolism and disposition. 2011, Vol 39, Num 9, pp 1478-1485, issn 0090-9556, 8 p.Article

Pemetrexed in malignant pleural mesotheliomaHAZARIKA, Maitreyee; WHITE, Robert M; MORSE, David E et al.Clinical cancer research. 2005, Vol 11, Num 3, pp 982-992, issn 1078-0432, 11 p.Article

Selective preservation of pemetrexed pharmacological activity in HeLa cells lacking the reduced folate carrier: Association with the presence of a secondary transport pathwayRONGBAO ZHAO; HANSCOM, Marie; CHATTOPADHYAY, Shrikanta et al.Cancer research (Baltimore). 2004, Vol 64, Num 9, pp 3313-3319, issn 0008-5472, 7 p.Article

Interaction of Radiation and Pemetrexed on a Human Malignant Mesothelioma Cell Line In VitroYOSHIDA, Daisaku; EBARA, Takeshi; SATO, Yumi et al.Anticancer research. 2011, Vol 31, Num 9, pp 2847-2851, issn 0250-7005, 5 p.Article

Pemetrexed-induced Eyelid Edema: Incidence and Clinical ManifestationsSCHALLIER, D; DECOSTER, L; FONTAINE, C et al.Anticancer research. 2010, Vol 30, Num 12, pp 5185-5188, issn 0250-7005, 4 p.Article

Caffeine markedly sensitizes human mesothelioma cell lines to pemetrexedSANG HEE MIN; GOLDMAN, I. David; RONGBAO ZHAO et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 5, pp 819-827, issn 0344-5704, 9 p.Article

Population pharmacokinetic analysis of ten phase II clinical trials of pemetrexed in cancer patientsLATZ, Jane E; CHAUDHARY, Ajai; GHOSH, Atalanta et al.Cancer chemotherapy and pharmacology. 2006, Vol 57, Num 4, pp 401-411, issn 0344-5704, 11 p.Article

Kinetic validation of the use of carboxydichlorofluorescein as a drug surrogate for MRP5-mediated transportPRATT, Susan; CHEN, Victor; PERRY, William I et al.European journal of pharmaceutical sciences. 2006, Vol 27, Num 5, pp 524-532, issn 0928-0987, 9 p.Article

The evolving role of pemetrexed (alimta) in lung cancerSOCINSKI, Mark A; STINCHCOMBE, Thomas E; HAYES, D. Neil et al.Seminars in oncology. 2005, Vol 32, Num 2, pp 16-22, issn 0093-7754, 7 p., SUP2Article

Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporterCHERIAN, Christina; KUGEL DESMOULIN, Sita; LEI WANG et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 4, pp 999-1011, issn 0344-5704, 13 p.Article

Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primatesSTAPLETON, Stacie L; REID, Joel M; THOMPSON, Patrick A et al.Cancer chemotherapy and pharmacology. 2007, Vol 59, Num 4, pp 461-466, issn 0344-5704, 6 p.Article

Physical instability of frozen pemetrexed solutions in PVC bagsYANPING ZHANG; TRISSEL, Lawrence A.The Annals of pharmacotherapy. 2006, Vol 40, Num 7-8, pp 1289-1292, issn 1060-0280, 4 p.Article

Painful generalized erythematous patches: A severe and unusual cutaneous reaction to pemetrexedVITIELLO, Magalys; ROMANELLI, Paolo; KERDEL, Francisco A et al.Journal of the American Academy of Dermatology. 2011, Vol 65, Num 1, pp 243-244, issn 0190-9622, 2 p.Article

Clinical investigation of malignant mesothelioma in JapanFUJIMOTO, Nobukazu; AOE, Keisuke; GEMBA, Kenichi et al.Journal of cancer research and clinical oncology. 2010, Vol 136, Num 11, pp 1755-1759, issn 0171-5216, 5 p.Article

Pemetrexed in the treatment of malignant mesothelioma: Results from an expanded access program in GermanyRECK, Martin; STAHEL, Rolf A; MANEGOLD, Christian et al.Respiratory medicine. 2010, Vol 104, Num 1, pp 142-148, issn 0954-6111, 7 p.Article